Gentaur

Systembio Distributor

Is Igm Iga Ige Or Igg More Effective In Circulating Antibodies For Neutralizing

Custom development of ELISAs for other species or antibody isotypes not listed in the catalog. Custom testing of samples for IgG/IgM/IgA or total (IgG+IgM+IgA)
000-CUS Custom
EUR 602

Ige Antibody Laboratories manufactures the is igm iga ige or igg more effective in circulating antibodies for neutralizing reagents distributed by Genprice. The Is Igm Iga Ige Or Igg More Effective In Circulating Antibodies For Neutralizing reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Is products are available in stock. Specificity: Is Category: Igm Group: Iga Ige

Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Measles/Rubeola vaccines by ELISA
Custom Ask for price

Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Chikungunya virus (CHIKV) by ELISA
Custom Ask for price

Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Diphtheria Toxin/Toxoid by ELISA
Custom Ask for price

Custom Testing of Samples for Antibodies (IgA/IgG/IgM) to Ovalbumin (Gal d2) by ELISA
Custom Ask for price

OARA05422-1MG - IgG IgA IgM Antibody
1mg
EUR 209

OARA05424-2MG - IgG IgA IgM Antibody
2mg
EUR 219

OARA05462-2MG - IgG IgA IgM Antibody
2mg
EUR 219

Iga Ige information

Anti-2019-nCoV S-IgM Neutralizing Antibody
MBS2564402-01mL 0.1mL
EUR 420

Anti-2019-nCoV S-IgM Neutralizing Antibody
MBS2564402-02mL 0.2mL
EUR 700

Anti-2019-nCoV S-IgM Neutralizing Antibody
MBS2564402-5x02mL 5x0.2mL
EUR 3110

Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5)
EPT018 50ug
EUR 199.5
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5)
EPT006 50ug
EUR 199.5
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Horse Anti-Rabies Virus IgG (Fab2), neutralizing
RBV16-Fab2 100 ul
EUR 534

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody
abx411283-02mg 0.2 mg
EUR 678

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody
abx411283-100g 100 µg Ask for price

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody
abx411283-25g 25 µg
EUR 487.5

COVID-19 S-IgA Human monoclonal neutralizing antibody
MB66247 50ul
EUR 275
Description: 1 mg/ml. Human IgA. Liquid in 0.01M Phosphate Buffered Saline, pH 7.4.

Circulating DNA Kit
abx098870-50rxns 50 rxns
EUR 477.6

Circulating DNA Kit
abx298027-50rxns 50 rxns
EUR 477.6

Circulating DNA Kit
AGDK-0041 Kit Ask for price
Description: Circulating DNA Kit is designed for For purification of cell-free DNA from plasma and serum samples. The kit utilizes our unique high-capacity magnetic bead technology that ensures efficient recovery of RNA fragment library within a desired fragment length range. The purified DNA is completely compatible with downstream application such as PCR, qPCR, genotyping, sequencing, Southern Blot analysis, and more. The system allows for automation after sample lysis via Hamilton STAR™, Thermo KingFisher™ Flex, Applied Biosystems® MagMAX™, Qiagen Biosprint, and other liquid handling instruments.

COVID-19 S-IgM Human monoclonal neutralizing antibody
MB66246 50ul
EUR 275
Description: 1 mg/ml. Human IgM. Liquid in 0.01M Phosphate Buffered Saline, pH 7.4.

Human Cells anti-COVID-19 S-IgA Neutralizing Antibody
DL99729A-100ul 100 ul
EUR 299
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein

Human Cells anti-COVID-19 S-IgA Neutralizing Antibody
DL99729A-50ul 50 ul
EUR 210
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein

Cytomegalovirus gB Late Neutralizing Antigen (CMV-LA gB Neutralizing) Antibody (FITC)
abx411284-01mg 0.1 mg
EUR 610.8